lncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/ β-catenin signaling pathways.

In conclusion, we revealed that down-regulation of GHET1 suppresses cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways, indicating GHET1 as a promising molecular biomarker for CC treatment improvement. PMID: 31682716 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31682716?dopt=Abstract

Source: Bioscience Reports - November 3, 2019 Category: Biomedical Science Authors: Liu Z, Luo S, Wu M, Huang C, Shi H, Song X Tags: Biosci Rep Source Type: research